Journal of medical case reports · 2021
A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aminimoghaddam Soheila, Afrooz Narjes, Nasiri Setare, Motaghi Nejad Ozra, Mahmoudzadeh Fatemeh
Аннотация
BACKGROUND: Pregnancy seems to increase the risk of thrombotic thrombocytopenic purpura (TTP) relapses and make the TTP more severe in any of the pregnancy trimesters, or even during the postpartum period.
CASE PRESENTATION: This study highlights details of treating a COVID-19 pregnant patient who survived. This 21-year addicted White woman was admitted at her 29th week and delivered a stillbirth. She was transferred to another hospital after showing signs of TTP, which was caused by a viral infection.
CONCLUSION: This viral infection caused fever and dyspnea, and the patient was tested positive for COVID-19 infection. A chest computed tomography scan showed diffuse multiple bilateral consolidations and interlobar septal thickening. She stayed at the Intensive Care Unit for 20 days and treated with plasmapheresis. As far as we know, this is the first report of a TTP pregnant patient with COVID-19 infection.
CASE PRESENTATION: This study highlights details of treating a COVID-19 pregnant patient who survived. This 21-year addicted White woman was admitted at her 29th week and delivered a stillbirth. She was transferred to another hospital after showing signs of TTP, which was caused by a viral infection.
CONCLUSION: This viral infection caused fever and dyspnea, and the patient was tested positive for COVID-19 infection. A chest computed tomography scan showed diffuse multiple bilateral consolidations and interlobar septal thickening. She stayed at the Intensive Care Unit for 20 days and treated with plasmapheresis. As far as we know, this is the first report of a TTP pregnant patient with COVID-19 infection.
Предметные рубрики MeSH
Acute Kidney InjuryAmphetamine-Related DisordersAntiviral AgentsCOVID-19Drug CombinationsErythrocyte TransfusionFemaleHemoglobinsHumansHydroxychloroquineIntensive Care UnitsL-Lactate DehydrogenaseLopinavirMethamphetaminePlasmapheresisPregnancyPregnancy Complications, HematologicPregnancy Complications, InfectiousPurpura, Thrombotic ThrombocytopenicRenal DialysisRitonavirSARS-CoV-2StillbirthTomography, X-Ray ComputedYoung Adult